In Situ, Autologous Therapeutic Vaccination Against Solid Cancers With Intratumoral Hiltonol®

Clinical trial NCT02423863 · COMPLETED

Trial details

NCT number: NCT02423863
Sponsor: Oncovir, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma Head and Neck Cancer Sarcoma Non-Melanoma Skin Cancers

Start date: 2015-03-01
Primary completion: 2020-08-31
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.